Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD

DMD 皮质类固醇治疗方案试验的生物统计学和数据管理

基本信息

  • 批准号:
    8100213
  • 负责人:
  • 金额:
    $ 57.33万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application requests funding for the data management and biostatistical support for an international multicenter clinical trial comparing three different corticosteroid (CS) regimens for the treatment of Duchenne muscular dystrophy (DMD). This is a companion application to that of Kate Bushby, M.D. from the University of Newcastle (UK) and Robert C. Griggs, M.D. from the University of Rochester (USA) entitled "FOR-DMD: Double-Blind Randomized Trial to Optimize Steroid Regimens in Duchenne MD." The primary aim of this project is to conduct an international multicenter, randomized, double-blind, controlled trial in which 300 children with DMD between the ages of 4 and 7 will be randomized to receive either daily prednisone (0.75 mg/kg), daily deflazacort (0.90 mg/kg), or intermittent (10 days on, 10 days off) prednisone (0.75 mg/kg) and followed for a minimum of three years. The primary outcome variable will be three-dimensional and will consist of (1) time to stand from lying (log-transformed), (2) forced vital capacity, and (3) subject/parent global satisfaction with treatment, all averaged over all post-baseline visits during the three-year follow-up period. The trial will address the pragmatic hypothesis that daily prednisone and daily deflazacort will be of greater benefit in terms of function and subject/parent satisfaction than intermittent CS (prednisone) given over a three-year period. The specific aims of our application are (1) To provide data management for the trial including: development and implementation of web-based randomization and enrollment procedures, provision of electronic case report forms, internet-facilitated entry of all study data into a standardized relational database, training of site personnel in the use of web-based applications for randomization and data entry, generation and resolution of data queries, monitoring of important study events, and maintenance of an appropriately secured and compliant network/database environment; and (2) To provide biostatistical support for the trial including: refinement and implementation of the statistical analysis plan to address the specific aims of the trial; design and implementation of an interim monitoring plan that will allow modification or termination of the study on the basis of early evidence of safety concerns, in conjunction with the NINDS-appointed Data and Safety Monitoring Board (DSMB); and preparation of open- and closed-session reports for the DSMB. PUBLIC HEALTH RELEVANCE: This trial is specifically designed to address the problems that have been raised as clinically relevant obstacles to establishing standards of practice in Duchenne muscular dystrophy (DMD), namely the lack of guidance on the relative efficacy and risks of different corticosteroid regimens and, in particular, the lack of long-term data. The current trial will generate practical guidance on the use of corticosteroids in DMD for immediate transfer into the clinic.
描述(由申请人提供):本申请要求为一项国际多中心临床试验的数据管理和生物统计支持提供资金,该试验比较了治疗杜氏肌营养不良症 (DMD) 的三种不同皮质类固醇 (CS) 方案。这是英国纽卡斯尔大学凯特·布什比医学博士和美国罗切斯特大学罗伯特·C·格里格斯医学博士题为“FOR-DMD:优化 Duchenne MD 类固醇治疗方案的双盲随机试验”的配套申请。该项目的主要目的是进行一项国际多中心、随机、双盲、对照试验,其中 300 名 4 岁至 7 岁之间患有 DMD 的儿童将随机接受每日泼尼松 (0.75 mg/kg)、每日地夫可特 (0.90 mg/kg) 或间歇性(10 天,休息 10 天)泼尼松 (0.75 mg/kg) 治疗,并随访至少 三年。主要结果变量将是三维的,包括(1)从说谎起立的时间(对数转换),(2)用力肺活量,以及(3)受试者/家长对治疗的整体满意度,所有这些都是三年随访期间所有基线后访视的平均值。该试验将提出一个务实的假设,即每日泼尼松和每日地夫可特在功能和受试者/家长满意度方面比三年期间给予间歇性 CS(泼尼松)具有更大的益处。我们应用程序的具体目标是(1)为试验提供数据管理,包括:开发和实施基于网络的随机化和登记程序,提供电子病例报告表,通过互联网将所有研究数据输入标准化关系数据库,培训现场人员使用基于网络的应用程序进行随机化和数据输入,生成和解决数据查询,监控重要的研究事件以及维护适当的安全和合规性 网络/数据库环境; (2) 为试验提供生物统计支持,包括:完善和实施统计分析计划,以实现试验的具体目标;与 NINDS 指定的数据和安全监测委员会 (DSMB) 一起设计和实施临时监测计划,该计划将允许根据安全问题的早期证据修改或终止研究;为 DSMB 准备公开会议和闭门会议报告。 公众健康相关性:本试验专门用于解决杜氏肌营养不良症 (DMD) 实践标准的临床相关障碍问题,即缺乏对不同皮质类固醇治疗方案的相对疗效和风险的指导,特别是缺乏长期数据。目前的试验将为 DMD 中使用皮质类固醇提供实用指导,以便立即转移到临床。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael P McDermott其他文献

Reference curves of motor function outcomes in young steroid‐naïve males with Duchenne muscular dystrophy
患有杜氏肌营养不良症的未接受类固醇治疗的年轻男性运动功能结果的参考曲线
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    J. Hoskens;Marianela Schiava;Nathalie Goemans;H. Feys;Michael P McDermott;William B Martens;A. Mayhew;Robert C. Griggs;K. Klingels;M. Guglieri
  • 通讯作者:
    M. Guglieri
Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders.
患有中度至重度免疫抑制的艾滋病毒阳性女性的疾病进展:抑郁症的作用。
  • DOI:
    10.1080/08964289909596738
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    K. Vedhara;G. Schifitto;Michael P McDermott
  • 通讯作者:
    Michael P McDermott
Examining the evidence for IL-2 in amyotrophic lateral sclerosis
研究白细胞介素-2在肌萎缩侧索硬化症中的相关证据
  • DOI:
    10.1016/s0140-6736(25)00901-8
  • 发表时间:
    2025-05-24
  • 期刊:
  • 影响因子:
    88.500
  • 作者:
    Michael Benatar;Michael P McDermott
  • 通讯作者:
    Michael P McDermott
The Huntington's Disease Health Index: Initial Evaluation of a Disease-Specific Patient Reported Outcome Measure.
亨廷顿病健康指数:对特定疾病患者报告的结果测量的初步评估。
  • DOI:
    10.3233/jhd-210506
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Olivia S. Brumfield;C. Zizzi;N. Dilek;Danae Alexandrou;Alistair Glidden;S. Rosero;Jennifer Weinstein;J. Seabury;A. Kaat;Michael P McDermott;E. Dorsey;C. Heatwole
  • 通讯作者:
    C. Heatwole
The Dolittle factor: 'Talking to the animals' during veterinary consultations.
杜立特因素:在兽医咨询期间“与动物交谈”。
  • DOI:
    10.1002/vetr.1380
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Michael P McDermott;M. Cobb;I. Robbé;R. Dean
  • 通讯作者:
    R. Dean

Michael P McDermott的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael P McDermott', 18)}}的其他基金

SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10188441
  • 财政年份:
    2020
  • 资助金额:
    $ 57.33万
  • 项目类别:
SLE Treatment with N-acetylcysteine
N-乙酰半胱氨酸治疗 SLE
  • 批准号:
    10462621
  • 财政年份:
    2020
  • 资助金额:
    $ 57.33万
  • 项目类别:
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center
高级分析研究核心将支持罗切斯特大学尤德尔中心的所有四个研究项目
  • 批准号:
    10242054
  • 财政年份:
    2018
  • 资助金额:
    $ 57.33万
  • 项目类别:
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center
高级分析研究核心将支持罗切斯特大学尤德尔中心的所有四个研究项目
  • 批准号:
    10459488
  • 财政年份:
    2018
  • 资助金额:
    $ 57.33万
  • 项目类别:
The Advanced Analytics Research Core will support all four Research Projects at the University of Rochester Udall Center
高级分析研究核心将支持罗切斯特大学尤德尔中心的所有四个研究项目
  • 批准号:
    10017336
  • 财政年份:
    2018
  • 资助金额:
    $ 57.33万
  • 项目类别:
Treatment of Systemic Lupus Erythematosus (SLE) with N-acetylcysteine (NAC)
N-乙酰半胱氨酸 (NAC) 治疗系统性红斑狼疮 (SLE)
  • 批准号:
    9173167
  • 财政年份:
    2016
  • 资助金额:
    $ 57.33万
  • 项目类别:
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD
DMD 皮质类固醇治疗方案试验的生物统计学和数据管理
  • 批准号:
    9763665
  • 财政年份:
    2010
  • 资助金额:
    $ 57.33万
  • 项目类别:
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD
DMD 皮质类固醇治疗方案试验的生物统计学和数据管理
  • 批准号:
    8672698
  • 财政年份:
    2010
  • 资助金额:
    $ 57.33万
  • 项目类别:
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD
DMD 皮质类固醇治疗方案试验的生物统计学和数据管理
  • 批准号:
    8314003
  • 财政年份:
    2010
  • 资助金额:
    $ 57.33万
  • 项目类别:
Biostatistics and Data Management for a Trial of Corticosteroid Regimens in DMD
DMD 皮质类固醇治疗方案试验的生物统计学和数据管理
  • 批准号:
    7783095
  • 财政年份:
    2010
  • 资助金额:
    $ 57.33万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 57.33万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了